Ivana Micallef, MD

  • 7255 Citations
  • 48 Scopus h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ivana Micallef is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 48 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Survival Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Lymphocyte Count Medicine & Life Sciences
Hematopoietic Stem Cell Mobilization Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 7255 Citations
  • 48 Scopus h-Index
  • 137 Article
  • 1 Comment/debate
  • 1 Letter

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.

Research output: Contribution to journalArticle

Autografts
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Survival
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Recurrence
Germinal Center
B-Lymphocytes
18 Citations (Scopus)

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, Slager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Clinical Trials
Lymphoma
Therapeutics
Selection Bias
3 Citations (Scopus)

History of autoimmune conditions and lymphoma prognosis

Kleinstern, G., Maurer, M. J., Liebow, M., Habermann, T. M., Koff, J. L., Allmer, C., Witzig, T. E., Nowakowski, G. S., Micallef, I., Johnston, P. B., Inwards, D. J., Thompson, C. A., Feldman, A. L., Link, B. K., Flowers, C., Slager, S. L. & Cerhan, J. R., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 73.

Research output: Contribution to journalArticle

Lymphoma
Disease-Free Survival
Hodgkin Disease
B-Lymphocytes
Survival